---
layout: default
title: Zero-Shot Large Language Model Agents for Fully Automated Radiotherapy Treatment Planning
---

# Zero-Shot Large Language Model Agents for Fully Automated Radiotherapy Treatment Planning

<div class="paper-toolbar">
  <div class="toolbar-left">
    <a href="https://arxiv.org/abs/2510.11754" target="_blank" class="toolbar-btn">arXiv: 2510.11754v1</a>
    <a href="https://arxiv.org/pdf/2510.11754.pdf" target="_blank" class="toolbar-btn">PDF</a>
  </div>
  <div class="toolbar-right">
    <button class="toolbar-btn favorite-btn" data-arxiv-id="2510.11754v1" 
            onclick="toggleFavorite(this, '2510.11754v1', 'Zero-Shot Large Language Model Agents for Fully Automated Radiotherapy Treatment Planning')" title="Êî∂Ëóè">
      ‚òÜ Êî∂Ëóè
    </button>
    <button class="toolbar-btn share-btn" onclick="copyLink()" title="Â§çÂà∂ÈìæÊé•">
      üîó ÂàÜ‰∫´
    </button>
  </div>
</div>


**‰ΩúËÄÖ**: Dongrong Yang, Xin Wu, Yibo Xie, Xinyi Li, Qiuwen Wu, Jackie Wu, Yang Sheng

**ÂàÜÁ±ª**: physics.med-ph, cs.AI, cs.RO

**ÂèëÂ∏ÉÊó•Êúü**: 2025-10-12

**Â§áÊ≥®**: Accepted for poster presentation at the NeurIPS 2025 Workshop on GenAI for Health: Potential, Trust, and Policy Compliance

---

## üí° ‰∏ÄÂè•ËØùË¶ÅÁÇπ

**ÊèêÂá∫Âü∫‰∫éÈõ∂Ê†∑Êú¨Â§ßËØ≠Ë®ÄÊ®°ÂûãÁöÑÂÖ®Ëá™Âä®ÊîæÂ∞ÑÊ≤ªÁñóËÆ°ÂàíÊñπÊ≥ïÔºåÊèêÂçáËÆ°ÂàíË¥®Èáè„ÄÇ**

üéØ **ÂåπÈÖçÈ¢ÜÂüü**: **ÊîØÊü±‰πùÔºöÂÖ∑Ë∫´Â§ßÊ®°Âûã (Embodied Foundation Models)**

**ÂÖ≥ÈîÆËØç**: `ÊîæÂ∞ÑÊ≤ªÁñóËÆ°Âàí` `Â§ßËØ≠Ë®ÄÊ®°Âûã` `Èõ∂Ê†∑Êú¨Â≠¶‰π†` `Ëá™Âä®Âåñ` `Ë∞ÉÂº∫ÊîæÂ∞ÑÊ≤ªÁñó` `ÈÄÜÂêë‰ºòÂåñ` `Â§¥È¢àÁôå`

## üìã Ê†∏ÂøÉË¶ÅÁÇπ

1. ÊâãÂä®ÊîæÂ∞ÑÊ≤ªÁñóËÆ°ÂàíËÄóÊó∂‰∏î‰æùËµñ‰∏ìÂÆ∂ÁªèÈ™åÔºåÈöæ‰ª•Êª°Ë∂≥Êó•ÁõäÂ¢ûÈïøÁöÑÁôåÁóáÊ≤ªÁñóÈúÄÊ±Ç„ÄÇ
2. Âà©Áî®Â§ßËØ≠Ë®ÄÊ®°ÂûãAgent‰∏éÊ≤ªÁñóËÆ°ÂàíÁ≥ªÁªü‰∫§‰∫íÔºåÂÆûÁé∞Èõ∂Ê†∑Êú¨ÁöÑËá™Âä®ÈÄÜÂêëÊ≤ªÁñóËÆ°Âàí„ÄÇ
3. ÂÆûÈ™åË°®ÊòéÔºåËØ•ÊñπÊ≥ïÂú®Âç±ÂèäÂô®ÂÆò‰øùÊä§ÊñπÈù¢‰∏é‰∏¥Â∫äËÆ°ÂàíÁõ∏ÂΩìÔºåÂπ∂Âú®ÁÉ≠ÁÇπÊéßÂà∂ÂíåÈÄÇÂΩ¢ÊÄßÊñπÈù¢ÊúâÊâÄÊèêÂçá„ÄÇ

## üìù ÊëòË¶ÅÔºà‰∏≠ÊñáÔºâ

ÊîæÂ∞ÑÊ≤ªÁñóËÆ°ÂàíÊòØ‰∏Ä‰∏™Ëø≠‰ª£‰∏î‰æùËµñ‰∏ìÂÆ∂ÁªèÈ™åÁöÑËøáÁ®ãÔºåÊó•ÁõäÂ¢ûÈïøÁöÑÁôåÁóáÁóÖ‰æã‰ΩøÂæó‰æùËµñÊâãÂä®ËÆ°ÂàíÂèòÂæóÈöæ‰ª•‰∏∫ÁªßÔºåÂõ†Ê≠§Ëá™Âä®ÂåñËá≥ÂÖ≥ÈáçË¶Å„ÄÇÊú¨Á†îÁ©∂ÊèêÂá∫‰∫Ü‰∏ÄÁßçÂà©Áî®Âü∫‰∫éÂ§ßËØ≠Ë®ÄÊ®°ÂûãÔºàLLMÔºâÁöÑAgentÊù•ÊåáÂØºË∞ÉÂº∫ÊîæÂ∞ÑÊ≤ªÁñóÔºàIMRTÔºâÈÄÜÂêëËÆ°ÂàíÁöÑÊµÅÁ®ã„ÄÇËØ•LLM AgentÁõ¥Êé•‰∏é‰∏¥Â∫äÊ≤ªÁñóËÆ°ÂàíÁ≥ªÁªüÔºàTPSÔºâ‰∫§‰∫íÔºåËø≠‰ª£Âú∞ÊèêÂèñ‰∏≠Èó¥ËÆ°ÂàíÁä∂ÊÄÅÂπ∂ÊèêÂá∫Êñ∞ÁöÑÁ∫¶ÊùüÂÄºÊù•ÊåáÂØºÈÄÜÂêë‰ºòÂåñ„ÄÇAgentÁöÑÂÜ≥Á≠ñËøáÁ®ãÂü∫‰∫éÂΩìÂâçÁöÑËßÇÂØüÂíå‰πãÂâçÁöÑ‰ºòÂåñÂ∞ùËØïÂèäËØÑ‰º∞Ôºå‰ªéËÄåÂÆûÁé∞Âä®ÊÄÅÁöÑÁ≠ñÁï•ÊîπËøõ„ÄÇËØ•ËÆ°ÂàíËøáÁ®ãÂú®Èõ∂Ê†∑Êú¨Êé®ÁêÜËÆæÁΩÆ‰∏≠ËøõË°åÔºåLLMÂú®Ê≤°Êúâ‰∫ãÂÖàÊé•Ëß¶ÊâãÂä®ÁîüÊàêÁöÑÊ≤ªÁñóËÆ°ÂàíÁöÑÊÉÖÂÜµ‰∏ãËøêË°åÔºåÂπ∂‰∏îÊ≤°ÊúâÁªèËøá‰ªª‰ΩïÂæÆË∞ÉÊàñÁâπÂÆö‰∫é‰ªªÂä°ÁöÑËÆ≠ÁªÉ„ÄÇÂú®20‰∏™Â§¥È¢àÁôåÁóÖ‰æã‰∏≠ÔºåLLMÁîüÊàêÁöÑËÆ°Âàí‰∏é‰∏¥Â∫äÊâãÂä®ËÆ°ÂàíËøõË°å‰∫ÜËØÑ‰º∞ÔºåÂàÜÊûêÂπ∂Êä•Âëä‰∫ÜÂÖ≥ÈîÆÁöÑÂâÇÈáèÂ≠¶ÁªàÁÇπ„ÄÇLLMÁîüÊàêÁöÑËÆ°ÂàíÂú®ÂÆûÁé∞‰∏é‰∏¥Â∫äËÆ°ÂàíÁõ∏ÂΩìÁöÑÂç±ÂèäÂô®ÂÆòÔºàOARÔºâ‰øùÊä§ÁöÑÂêåÊó∂ÔºåË°®Áé∞Âá∫ÊîπËøõÁöÑÁÉ≠ÁÇπÊéßÂà∂ÔºàDmaxÔºö106.5ÔºÖ vs. 108.8ÔºÖÔºâÂíå‰ºòÂºÇÁöÑÈÄÇÂΩ¢ÊÄßÔºàboost PTVÁöÑÈÄÇÂΩ¢ÊåáÊï∞Ôºö1.18 vs. 1.39Ôºõprimary PTVÁöÑÈÄÇÂΩ¢ÊåáÊï∞Ôºö1.82 vs. 1.88Ôºâ„ÄÇËøôÈ°πÁ†îÁ©∂ËØÅÊòé‰∫ÜÂú®ÂïÜ‰∏öTPS‰∏≠ÔºåÈõ∂Ê†∑Êú¨„ÄÅLLMÈ©±Âä®ÁöÑËá™Âä®ÂåñIMRTÊ≤ªÁñóËÆ°ÂàíÂ∑•‰ΩúÊµÅÁ®ãÁöÑÂèØË°åÊÄß„ÄÇÊâÄÊèêÂá∫ÁöÑÊñπÊ≥ïÊèê‰æõ‰∫Ü‰∏ÄÁßçÈÄöÁî®‰∏î‰∏¥Â∫ä‰∏äÈÄÇÁî®ÁöÑËß£ÂÜ≥ÊñπÊ°àÔºåÂèØ‰ª•ÂáèÂ∞ëËÆ°ÂàíÁöÑÂèòÂºÇÊÄßÔºåÂπ∂ÊîØÊåÅÊõ¥ÂπøÊ≥õÂú∞ÈááÁî®Âü∫‰∫éAIÁöÑËÆ°ÂàíÁ≠ñÁï•„ÄÇ

## üî¨ ÊñπÊ≥ïËØ¶Ëß£

**ÈóÆÈ¢òÂÆö‰πâ**ÔºöÊîæÂ∞ÑÊ≤ªÁñóËÆ°ÂàíÁöÑÈÄÜÂêë‰ºòÂåñÊòØ‰∏Ä‰∏™Â§çÊùÇ‰∏îËø≠‰ª£ÁöÑËøáÁ®ãÔºåÈúÄË¶ÅÊîæÂ∞ÑËÇøÁò§Â≠¶ÂÆ∂ÂíåÁâ©ÁêÜÂ∏àÁöÑ‰∏ì‰∏öÁü•ËØÜ„ÄÇÊâãÂä®ËÆ°ÂàíËÄóÊó∂‰∏îÂÆπÊòìÂá∫Áé∞‰∫∫‰∏∫ËØØÂ∑ÆÔºå‰∏çÂêåËÆ°ÂàíËÄÖ‰πãÈó¥‰πüÂ≠òÂú®Â∑ÆÂºÇ„ÄÇÁé∞ÊúâÁöÑËá™Âä®ÂåñÊñπÊ≥ïÈÄöÂ∏∏ÈúÄË¶ÅÂ§ßÈáèÊâãÂä®ËÆ°ÂàíÊï∞ÊçÆËøõË°åËÆ≠ÁªÉÔºåÊ≥õÂåñËÉΩÂäõÊúâÈôê„ÄÇ

**Ê†∏ÂøÉÊÄùË∑Ø**ÔºöÂà©Áî®Â§ßËØ≠Ë®ÄÊ®°ÂûãÔºàLLMÔºâÁöÑÂº∫Â§ßÊé®ÁêÜËÉΩÂäõÔºåÂ∞ÜÂÖ∂‰Ωú‰∏∫‰∏Ä‰∏™Êô∫ËÉΩAgentÔºåÁõ¥Êé•‰∏é‰∏¥Â∫äÊ≤ªÁñóËÆ°ÂàíÁ≥ªÁªüÔºàTPSÔºâ‰∫§‰∫í„ÄÇAgentÈÄöËøáËßÇÂØüÂΩìÂâçÁöÑËÆ°ÂàíÁä∂ÊÄÅÔºåÁªìÂêà‰πãÂâçÁöÑ‰ºòÂåñÂ∞ùËØïÂíåËØÑ‰º∞ÁªìÊûúÔºåÂä®ÊÄÅÂú∞Ë∞ÉÊï¥‰ºòÂåñÁ≠ñÁï•Ôºå‰ªéËÄåÂÆûÁé∞Ëá™Âä®ÂåñÁöÑÈÄÜÂêëËÆ°Âàí„ÄÇËøôÁßçÊñπÊ≥ïÊó†ÈúÄÈ¢ÑÂÖàËÆ≠ÁªÉÊàñÂæÆË∞ÉÔºåÂÖ∑ÊúâËâØÂ•ΩÁöÑÊ≥õÂåñËÉΩÂäõ„ÄÇ

**ÊäÄÊúØÊ°ÜÊû∂**ÔºöÊï¥‰ΩìÊµÅÁ®ãÂåÖÊã¨‰ª•‰∏ãÂá†‰∏™‰∏ªË¶ÅÊ≠•È™§Ôºö1) LLM AgentÂàùÂßãÂåñÔºåËÆæÂÆö‰ºòÂåñÁõÆÊ†áÂíåÁ∫¶ÊùüÊù°‰ª∂Ôºõ2) Agent‰∏éTPS‰∫§‰∫íÔºåÊèêÂèñÂΩìÂâçËÆ°ÂàíÁä∂ÊÄÅÔºàÂ¶ÇÂâÇÈáèÂàÜÂ∏É„ÄÅDVHÁ≠âÔºâÔºõ3) AgentÂü∫‰∫éÂΩìÂâçÁä∂ÊÄÅÂíåÂéÜÂè≤ÁªèÈ™åÔºåÊèêÂá∫Êñ∞ÁöÑÁ∫¶ÊùüÂÄºÔºåÊåáÂØºTPSËøõË°åÈÄÜÂêë‰ºòÂåñÔºõ4) TPSÊ†πÊçÆAgentÊèêÂá∫ÁöÑÁ∫¶ÊùüÂÄºËøõË°å‰ºòÂåñÔºåÁîüÊàêÊñ∞ÁöÑËÆ°ÂàíÔºõ5) AgentËØÑ‰º∞Êñ∞ËÆ°ÂàíÁöÑË¥®ÈáèÔºåÂπ∂Êõ¥Êñ∞‰ºòÂåñÁ≠ñÁï•Ôºõ6) ÈáçÂ§çÊ≠•È™§2-5ÔºåÁõ¥Âà∞Êª°Ë∂≥‰ºòÂåñÁõÆÊ†áÊàñËææÂà∞ÊúÄÂ§ßËø≠‰ª£Ê¨°Êï∞„ÄÇ

**ÂÖ≥ÈîÆÂàõÊñ∞**ÔºöËØ•ÊñπÊ≥ïÁöÑÊ†∏ÂøÉÂàõÊñ∞Âú®‰∫éÂà©Áî®Èõ∂Ê†∑Êú¨Â≠¶‰π†ÁöÑÂ§ßËØ≠Ë®ÄÊ®°ÂûãAgentÔºåÁõ¥Êé•‰∏é‰∏¥Â∫äTPS‰∫§‰∫íÔºåÂÆûÁé∞ÂÖ®Ëá™Âä®ÁöÑÊîæÂ∞ÑÊ≤ªÁñóËÆ°Âàí„ÄÇ‰∏é‰º†ÁªüÁöÑÁõëÁù£Â≠¶‰π†ÊñπÊ≥ïÁõ∏ÊØîÔºåËØ•ÊñπÊ≥ïÊó†ÈúÄÂ§ßÈáèÊâãÂä®ËÆ°ÂàíÊï∞ÊçÆËøõË°åËÆ≠ÁªÉÔºåÂÖ∑ÊúâÊõ¥Â•ΩÁöÑÊ≥õÂåñËÉΩÂäõÂíåÈÄÇÂ∫îÊÄß„ÄÇÊ≠§Â§ñÔºåAgentÁöÑÂÜ≥Á≠ñËøáÁ®ãÊòØÂä®ÊÄÅÁöÑÔºåÂèØ‰ª•Ê†πÊçÆÂΩìÂâçÁöÑËÆ°ÂàíÁä∂ÊÄÅÂíåÂéÜÂè≤ÁªèÈ™åËøõË°åË∞ÉÊï¥Ôºå‰ªéËÄåÂÆûÁé∞Êõ¥‰ºòÁöÑ‰ºòÂåñÁªìÊûú„ÄÇ

**ÂÖ≥ÈîÆËÆæËÆ°**ÔºöAgentÁöÑËÆæËÆ°ÂåÖÊã¨‰ª•‰∏ãÂá†‰∏™ÂÖ≥ÈîÆÊñπÈù¢Ôºö1) Áä∂ÊÄÅË°®Á§∫ÔºöAgentÈúÄË¶ÅËÉΩÂ§üÂáÜÁ°ÆÂú∞ÁêÜËß£ÂΩìÂâçÁöÑËÆ°ÂàíÁä∂ÊÄÅÔºåÂåÖÊã¨ÂâÇÈáèÂàÜÂ∏É„ÄÅDVH„ÄÅÂç±ÂèäÂô®ÂÆòÁöÑÂâÇÈáèÁ≠â‰ø°ÊÅØ„ÄÇ2) Âä®‰ΩúÁ©∫Èó¥ÔºöAgentÈúÄË¶ÅËÉΩÂ§üÊèêÂá∫ÊúâÊïàÁöÑÁ∫¶ÊùüÂÄºÔºåÊåáÂØºTPSËøõË°åÈÄÜÂêë‰ºòÂåñ„ÄÇ3) Â•ñÂä±ÂáΩÊï∞ÔºöAgentÈúÄË¶ÅËÉΩÂ§üËØÑ‰º∞ËÆ°ÂàíÁöÑË¥®ÈáèÔºåÂπ∂Ê†πÊçÆËØÑ‰º∞ÁªìÊûúË∞ÉÊï¥‰ºòÂåñÁ≠ñÁï•„ÄÇ4) Êé¢Á¥¢Á≠ñÁï•ÔºöAgentÈúÄË¶ÅÂú®Êé¢Á¥¢Êñ∞ÁöÑ‰ºòÂåñÁ≠ñÁï•ÂíåÂà©Áî®Â∑≤ÊúâÁöÑÁªèÈ™å‰πãÈó¥ËøõË°åÂπ≥Ë°°„ÄÇ

## üìä ÂÆûÈ™å‰∫ÆÁÇπ

Âú®20‰∏™Â§¥È¢àÁôåÁóÖ‰æãÁöÑÂÆûÈ™å‰∏≠ÔºåLLMÁîüÊàêÁöÑËÆ°ÂàíÂú®Âç±ÂèäÂô®ÂÆò‰øùÊä§ÊñπÈù¢‰∏é‰∏¥Â∫äÊâãÂä®ËÆ°ÂàíÁõ∏ÂΩìÔºåÂπ∂‰∏îÂú®ÁÉ≠ÁÇπÊéßÂà∂ÔºàDmaxÔºö106.5ÔºÖ vs. 108.8ÔºÖÔºâÂíåÈÄÇÂΩ¢ÊÄßÔºàboost PTVÁöÑÈÄÇÂΩ¢ÊåáÊï∞Ôºö1.18 vs. 1.39Ôºõprimary PTVÁöÑÈÄÇÂΩ¢ÊåáÊï∞Ôºö1.82 vs. 1.88ÔºâÊñπÈù¢ÊúâÊâÄÊèêÂçá„ÄÇËøô‰∫õÁªìÊûúË°®ÊòéÔºåËØ•ÊñπÊ≥ïÂÖ∑ÊúâËâØÂ•ΩÁöÑ‰∏¥Â∫äÂ∫îÁî®ÊΩúÂäõ„ÄÇ

## üéØ Â∫îÁî®Âú∫ÊôØ

ËØ•Á†îÁ©∂ÊàêÊûúÂèØÂ∫îÁî®‰∫é‰∏¥Â∫äÊîæÂ∞ÑÊ≤ªÁñóËÆ°ÂàíÁöÑËá™Âä®ÂåñÔºåÂáèÂ∞ëËÆ°ÂàíÊó∂Èó¥Âíå‰∫∫‰∏∫ËØØÂ∑ÆÔºåÊèêÈ´òËÆ°ÂàíË¥®ÈáèÂíå‰∏ÄËá¥ÊÄß„ÄÇËØ•ÊñπÊ≥ïÂÖ∑ÊúâËâØÂ•ΩÁöÑÊ≥õÂåñËÉΩÂäõÔºåÂèØ‰ª•Â∫îÁî®‰∫é‰∏çÂêåÁ±ªÂûãÁöÑÁôåÁóáÂíåÊ≤ªÁñóÊäÄÊúØ„ÄÇÊ≠§Â§ñÔºåËØ•ÊñπÊ≥ïËøòÂèØ‰ª•‰Ωú‰∏∫ËæÖÂä©Â∑•ÂÖ∑ÔºåÂ∏ÆÂä©ÊîæÂ∞ÑËÇøÁò§Â≠¶ÂÆ∂ÂíåÁâ©ÁêÜÂ∏àÊõ¥Â•ΩÂú∞ÁêÜËß£Âíå‰ºòÂåñÊ≤ªÁñóËÆ°Âàí„ÄÇ

## üìÑ ÊëòË¶ÅÔºàÂéüÊñáÔºâ

> Radiation therapy treatment planning is an iterative, expertise-dependent process, and the growing burden of cancer cases has made reliance on manual planning increasingly unsustainable, underscoring the need for automation. In this study, we propose a workflow that leverages a large language model (LLM)-based agent to navigate inverse treatment planning for intensity-modulated radiation therapy (IMRT). The LLM agent was implemented to directly interact with a clinical treatment planning system (TPS) to iteratively extract intermediate plan states and propose new constraint values to guide inverse optimization. The agent's decision-making process is informed by current observations and previous optimization attempts and evaluations, allowing for dynamic strategy refinement. The planning process was performed in a zero-shot inference setting, where the LLM operated without prior exposure to manually generated treatment plans and was utilized without any fine-tuning or task-specific training. The LLM-generated plans were evaluated on twenty head-and-neck cancer cases against clinical manual plans, with key dosimetric endpoints analyzed and reported. The LLM-generated plans achieved comparable organ-at-risk (OAR) sparing relative to clinical plans while demonstrating improved hot spot control (Dmax: 106.5% vs. 108.8%) and superior conformity (conformity index: 1.18 vs. 1.39 for boost PTV; 1.82 vs. 1.88 for primary PTV). This study demonstrates the feasibility of a zero-shot, LLM-driven workflow for automated IMRT treatment planning in a commercial TPS. The proposed approach provides a generalizable and clinically applicable solution that could reduce planning variability and support broader adoption of AI-based planning strategies.

